<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/><meta name="exporter-version" content="Evernote Mac 7.14 (458244)"/><meta name="author" content="taylor.arhar@gmail.com"/><meta name="created" content="2018-06-20 18:06:11 +0000"/><meta name="source" content="desktop.mac"/><meta name="updated" content="2018-06-21 00:54:59 +0000"/><title>June 20, 2018</title></head><body><div>Restriction digest:</div><div>- goal: digest 0N4R WT pET28a plasmid and empty pMCSG7 plasmid with XbaI and XhoI restriction enzymes to make them compatible for future ligation; overall goal is to move 0N4R WT gene into pMCSG7 plasmid to change antibiotic resistance markers, so that 0N4R WT can be expressed in the new PatZ deletion strain that already has kan resistance</div><div>- combined vectors, nuclease-free water, CutSmart buffer, and enzymes as describedÂ (see attached)</div><div>- vortexed, spun, and let incubate at 37C for 1 hr</div><div><br/></div><div>Gel purification of restriction products:</div><div>- run both restriction digest reactions on a 0.7% agarose gel, 2.5ug/mL ethidium bromide</div><div>- Kelly performed gel extraction from kit as described</div><div>- nano dropped for DNA concentrations</div><div><br/></div><div>Ligation and transformation:</div><div>- performed ligation as described, using a 3:1 ratio of insert to vector</div><div>- transformed 5uL of each reaction into NovaBlue cells and plated on amp plates</div><div><br/></div><div><img src="June%2020,%202018.html.resources/IMG_1488.JPG" /><br/></div><div><br/></div></body></html>
